- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Vertex Pharmaceuticals Inc+ Add to Watchlist
VRTX:US133.2000 USD 2.6200 1.93%
As of 20:10:00 ET on 04/24/2015.
Company Profile for Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.
Vertex Pharmaceuticals Inc
Key Executives for Vertex Pharmaceuticals Inc (VRTX)
|Jeffrey M Leiden "Jeff"Chairman/President/CEO||Ian F SmithExec VP/CFO|
|Stuart A ArbuckleExec VP/Chief Commercial Ofcr||David AltshulerExec VP:Global Research|
|Jeffrey A Chodakewitz "Jeff"Exec VP:Global Medicines Dev||Amit K SachdevExec VP:Global Govt Strategy|
|Kenneth S BogerSenior VP/Secy/Gen Cnsl||Paul M SilvaSenior VP/Controller|
|Michael PartridgeVP:Investor Relations||Kelly LewisDirector:Investor Relations|